Cannabis research has historically focused on the most prevalent cannabinoids. However, extracts with a broad spectrum of secondary metabolites may have increased efficacy and decreased adverse effects compared to cannabinoids in isolation. Cannabis's complexity contributes to the length and breadth of its historical usage, including the individual application of the leaves, stem barks, and roots, for which modern research has not fully developed its therapeutic potential. This study is the first attempt to profile secondary metabolites groups in individual plant parts comprehensively. We profiled 14 cannabinoids, 47 terpenoids (29 monoterpenoids, 15 sesquiterpenoids, and 3 triterpenoids), 3 sterols, and 7 flavonoids in cannabis flowers, leaves, stem barks, and roots in three chemovars available. Cannabis inflorescence was characterized by cannabinoids (15.77-20.37%), terpenoids (1.28-2.14%), and flavonoids (0.07-0.14%); the leaf by cannabinoids (1.10-2.10%), terpenoids (0.13-0.28%), and flavonoids (0.34-0.44%); stem barks by sterols (0.07-0.08%) and triterpenoids (0.05-0.15%); roots by sterols (0.06-0.09%) and triterpenoids (0.13-0.24%). This comprehensive profile of bioactive compounds can form a baseline of reference values useful for research and clinical studies to understand the "entourage effect" of cannabis as a whole, and also to rediscover therapeutic potential for each part of cannabis from their traditional use by applying modern scientific methodologies. Cannabis is a complex herbal medicine containing several classes of secondary metabolites, including at least 104 cannabinoids, 120 terpenoids (including 61 monoterpenes, 52 sesquiterpenoids, and 5 triterpenoids), 26 flavonoids, and 11 steroids among 545 identified compounds 1-6. The postulated biosynthetic pathways for these metabolite groups 7,8 are outlined in Fig. 1. Cannabis has attracted a new wave of interest for its broad medicinal applications as 1) an analgesic, potentially as an adjunct to or substitute for opiates in the treatment of chronic pain 9 , and 2) an appetite stimulant and digestive aid 10 , among others. Since the 1960s, the research has focussed mainly on cannabinoids, ∆ 9-tetrahydrocannabinol (∆ 9-THC), and cannabidiol (CBD) in particular 11-28. The major psychoactive content expressed as total THC decreases in the order of inflorescences (10-12%), leaves (1-2%), stems (0.1-0.3%), roots (<0.03%), and seeds (generally absent) 29. As such, female flower tops are harvested while other parts are often discarded by growers 29. This is a potentially unnecessary waste. As an ancient medicine in various cultures, each part of the cannabis plant has been historically indicated with a wide range of applications relating mostly to painkilling, inflammation releasing, and mental illness treatment 30-33. Compounds other than ∆ 9-THC and CBD may contribute to the therapeutic effects of each plant part in their traditional uses. Minor cannabinoids, such as cannabinol (CBN), cannabigerol (CBG), cannabichromene (CBC), also have broad therapeu...